Our clinical trial auditing firm wants to use AI to draft regulatory compliance reviews, but our industry regulators demand full auditability and hold us personally liable for any algorithmic hallucinations. How do we structure this workflow on our Accountability Chart so we do not lose our license?

Question

Tyler Smith · Accepted Answer

In a highly regulated environment, you cannot treat AI as the decision-maker. It is purely an assistant. To protect your firm, you must design a human-in-the-loop workflow and clearly define it on your Accountability Chart.

Create a specific quality control seat on your Accountability Chart. The person in this seat is responsible for auditing and signing off on every AI-generated draft before it goes to a client or regulator. They must have the capability and capacity to spot subtle errors that the AI might generate.

Do not allow AI tools to publish reports directly. Your operational process must dictate that the AI only outputs a first draft.

Modify your standard operating procedures to include a dual-signature sign-off process. The first signature is from the specialist who generated the report using AI, confirming they verified the sources. The second signature is from your quality control seat.

By enforcing this structure, you maintain the speed benefit of automated drafting while keeping your liability firmly managed by qualified humans who GWC™ the work.